Skip to main content
logo
Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Aug 28, 2026, 4:00 PM EDT
1.116
+0.006 (0.54%)
After-hours: Aug 28, 2026, 5:46 PM EDT

Pliant Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.589.697.57
Revenue Growth
----83.69%27.91%-81.89%
Gross Profit
---1.589.697.57
Operating Income
-91.18-150.07-228.37-184.15-127.2-97.54
Net Income
-92.29-149.34-210.3-161.34-123.32-97.26
Earnings Per Share
-1.50-2.43-3.47-2.75-2.94-2.71
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
158.1190.94355.72494.25331.19200.6
Total Debt
28.7429.1160.1911.3715.827.19
Net Cash (Debt)
129.36161.84295.53482.87315.37193.4
Net Cash Growth
-36.12%-45.24%-38.80%53.11%63.07%-30.15%
Net Cash Per Share
2.102.644.888.227.515.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-70.9-128.34-155.5-116.36-94.63-75.44
Capital Expenditures
--0.37-3.85-0.92-1.76-1.95
Free Cash Flow
-70.9-128.71-159.35-117.28-96.39-77.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----11654.75%-1313.37%-1288.10%
Pretax Margin
----10211.14%-1273.32%-1284.51%
Profit Margin
----10211.14%-1273.32%-1284.51%
FCF Margin
----7422.91%-995.26%-1022.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---686.5397.3264.25